Funding for this research was provided by:
Canadian Intiative for Outcomes in Rheumatology Care
Text and Data Mining valid from 2018-07-05
Received: 26 February 2018
Accepted: 11 June 2018
First Online: 5 July 2018
Ethics approval and consent to participate
: Ethical approval for the study was granted by the UBC Behavioural Research Ethics Board (H15–01948). Written consent was obtained from all participants.
: Not applicable.
: CK, KM and LS have no competing interests to declare. SM holds a Michael Smith Foundation for Health Research Trainee Award 2016 (#16603). MHu is funded as a Clinician Scientist by the Fonds de recherché en Santé du Québec. MHa is supported by The Arthritis Society Young Investigator Salary Award 2016 (YIS-16-104) and a Michael Smith Foundation for Health Research Scholar Award 2017 (#16813). MHa holds the UBC Professorship in Sustainable Health Care, which is funded by AmgenCanada, AstraZeneca Canada, Eli Lilly Canada, GlaxoSmithKline, Merck Canada, Novartis Pharmaceuticals Canada, Pfizer Canada, Boehringer Ingelheim (Canada), Hoffman-La Roche, LifeScan Canada, and Lundbeck Canada.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.